4//SEC Filing
Grossman Jerrold B 4
Accession 0001140361-22-008670
CIK 0001368514other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:58 PM ET
Size
10.6 KB
Accession
0001140361-22-008670
Insider Transaction Report
Form 4
Grossman Jerrold B
Director
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-07+53,172→ 53,172 totalExercise: $1.67Exp: 2032-03-07→ Common Stock (53,172 underlying) - Award
Common Stock
2022-03-07+26,586→ 287,450 total
Holdings
- 31,381(indirect: See footnote)
Common Stock
- 175(indirect: See footnote)
Common Stock
- 22,857(indirect: See footnote)
Common Stock
- 38,294(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
- [F2]Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 260,864 shares of common stock owned by the reporting person.
- [F3]These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
- [F4]These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
- [F5]These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
- [F6]These shares are owned by the reporting person's wife.
- [F7]The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001542519
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:58 PM ET
- Size
- 10.6 KB